Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.

Liu Y, Zhang AQ, Cao L, Xia HT, Ma JJ.

PLoS One. 2013 Nov 21;8(11):e79417. doi: 10.1371/journal.pone.0079417. eCollection 2013. Review.

2.

Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.

Al-Amin AH, Sarveswaran J, Wood JM, Burke DA, Donnellan CF.

J Vasc Access. 2013 Oct-Dec;14(4):379-82. doi: 10.5301/jva.5000168. Epub 2013 Jul 1.

PMID:
23817948
3.

Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.

Klek S, Szczepanek K, Hermanowicz A, Galas A.

JPEN J Parenter Enteral Nutr. 2015 Mar;39(3):331-5. doi: 10.1177/0148607114525804. Epub 2014 Mar 6.

PMID:
24604029
4.

Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S.

Cochrane Database Syst Rev. 2016 Mar 16;3:CD007878. doi: 10.1002/14651858.CD007878.pub3. Review.

PMID:
26982376
5.

Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.

Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P.

Am J Kidney Dis. 2014 Mar;63(3):479-90. doi: 10.1053/j.ajkd.2013.08.016. Epub 2013 Oct 11. Review.

PMID:
24125729
6.

Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.

van de Wetering MD, van Woensel JB, Lawrie TA.

Cochrane Database Syst Rev. 2013 Nov 25;(11):CD003295. doi: 10.1002/14651858.CD003295.pub3. Review.

PMID:
24277633
7.
8.

Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials.

Zacharioudakis IM, Zervou FN, Arvanitis M, Ziakas PD, Mermel LA, Mylonakis E.

Clin Infect Dis. 2014 Dec 15;59(12):1741-9. doi: 10.1093/cid/ciu671. Epub 2014 Aug 25.

PMID:
25156111
9.

Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.

Olthof ED, Rentenaar RJ, Rijs AJ, Wanten GJ.

Clin Nutr. 2013 Aug;32(4):538-42. doi: 10.1016/j.clnu.2012.11.014. Epub 2012 Dec 5.

PMID:
23267744
10.

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.

Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ.

Clin Nutr. 2010 Aug;29(4):464-8. doi: 10.1016/j.clnu.2009.12.005. Epub 2010 Jan 12.

PMID:
20061070
11.

Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.

Dümichen MJ, Seeger K, Lode HN, Kühl JS, Ebell W, Degenhardt P, Singer M, Geffers C, Querfeld U.

J Hosp Infect. 2012 Apr;80(4):304-9. doi: 10.1016/j.jhin.2012.01.003. Epub 2012 Feb 18.

PMID:
22342714
12.

Antibiotic lock for the prevention of catheter-related infection in neonates.

Taylor JE, Tan K, Lai NM, McDonald SJ.

Cochrane Database Syst Rev. 2015 Jun 4;(6):CD010336. doi: 10.1002/14651858.CD010336.pub2. Review.

PMID:
26040840
13.

Treatment of long-term catheter-related bloodstream infections with a taurolidine block: a single cancer center experience.

Haag GM, Berger AK, Jäger D.

J Vasc Access. 2011 Jul-Sep;12(3):244-7. doi: 10.5301/JVA.2011.6265.

PMID:
21279949
14.

Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients.

Touré A, Lauverjat M, Peraldi C, Boncompain-Gerard M, Gelas P, Barnoud D, Chambrier C.

Clin Nutr. 2012 Aug;31(4):567-70. doi: 10.1016/j.clnu.2012.01.001. Epub 2012 Jan 28.

PMID:
22285029
15.

Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.

Olthof ED, Versleijen MW, Huisman-de Waal G, Feuth T, Kievit W, Wanten GJ.

PLoS One. 2014 Nov 7;9(11):e111216. doi: 10.1371/journal.pone.0111216. eCollection 2014.

16.

A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.

Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schulz M, Diggle P.

Am J Kidney Dis. 2010 Jun;55(6):1060-8. doi: 10.1053/j.ajkd.2009.11.025. Epub 2010 Mar 6.

PMID:
20207458
17.

Microbiocidal effects of various taurolidine containing catheter lock solutions.

Olthof ED, Nijland R, Gülich AF, Wanten GJ.

Clin Nutr. 2015 Apr;34(2):309-14. doi: 10.1016/j.clnu.2014.04.023. Epub 2014 May 9.

PMID:
24861410
18.

Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S.

Cochrane Database Syst Rev. 2013 Jun 6;(6):CD007878. doi: 10.1002/14651858.CD007878.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;3:CD007878.

PMID:
23740696
19.

Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections.

Jurewitsch B, Lee T, Park J, Jeejeebhoy K.

JPEN J Parenter Enteral Nutr. 1998 Jul-Aug;22(4):242-4.

PMID:
9661127
20.

Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.

Handrup MM, Fuursted K, Funch P, Møller JK, Schrøder H.

APMIS. 2012 Oct;120(10):794-801. doi: 10.1111/j.1600-0463.2012.02910.x. Epub 2012 May 15.

PMID:
22958287

Supplemental Content

Support Center